Lion's Mane (Hericium erinaceus) for Parkinson's Disease
Also known as: Hericium erinaceus, Yamabushitake
Lion's mane's neurotrophic factor stimulation (NGF, BDNF) may support dopaminergic neuron survival in Parkinson's.
Mechanism of Action
In Parkinson's, lion's mane-induced BDNF and NGF may support dopaminergic neuron survival and promote compensatory neuroplasticity. Erinacines have demonstrated anti-inflammatory effects relevant to Parkinson's neuroinflammation and may support myelination in affected pathways.
General mechanism: Medicinal mushroom. Hericenones/erinacines stimulate NGF and BDNF synthesis via JNK pathway. Anti-inflammatory, ER stress reduction.
Current Evidence
Preclinical evidence shows neuroprotective effects in neurotoxin-induced Parkinson's models. No clinical trials specific to Parkinson's. The neurotrophic mechanism is well-characterized.
Clinical Status: Preclinical for Parkinson's. Available as supplement.
Safety Profile
Excellent safety. Generally well-tolerated as food and supplement. Rare allergic reactions in mushroom-sensitive individuals.
Key Research Questions
- Can lion's mane BDNF stimulation complement exercise-induced neuroplasticity in PD?
- Does long-term lion's mane supplementation slow cognitive decline in PD dementia?
Frequently Asked Questions
Does lion's mane help with Alzheimer's?
Lion's mane (Hericium erinaceus) stimulates nerve growth factor (NGF) synthesis through hericenones and erinacines. Clinical studies show improved cognitive function in mild cognitive impairment. It may support neurogenesis in the hippocampus. Research for Alzheimer's specifically is preclinical but promising.
Lion's mane dosage for brain health
Clinical trials have used 750mg-3000mg daily of dried mushroom extract (standardized to hericenones/erinacines). Most cognitive benefit studies use 1000mg three times daily. Dual extraction (hot water + alcohol) preserves both hericenones and erinacines.